Clinical Professionals Christmas 2014 Opening Hours

The Clinical Professionals Group will be closed from the afternoon of the 24th December 2014 until Friday 2nd January 2015.

We would like to wish all our clients and candidates a very Merry Christmas and Happy New Year!

The Clinical Professionals Group have had a very successful 2014 and we would like to thank everyone we have worked with in the past year.  We look forward to working with you in 2015.

If you need to contact us over the holidays, please leave a message on our voicemail and we will respond to you as soon as possible.

The Clinical Professionals Team

Clinical Professionals Raise Money for Save the Children

Clinical Professionals Raise Money for Save the Children

On Friday, the Clinical Professionals Group took part in Christmas Jumper Day, raising money for Save the Children.

Employees paid £1 to wear their Christmas jumper (or outfit) to work, with employees who forgot being fined £2.  Employees also baked cakes to bring in and sell, raising more money for the charity.

2014 was the third Christmas Jumper Day, raising money for the charity, Save the Children.

Save the Children works across in 120 countries.  The charity helps children who are in emergency situations, in poverty, missing out on school, suffering from hunger and health problems, or in danger of exploitation or neglect.  The charity helped 15.4 million children through their work in 2013.

Clinical Professionals’ CEO, Yvette Cleland, commented:
“This Xmas Clinical Professionals has filled 60 toy boxes for under privileged children and to round our activities up we also decided to support the wonderful Save the Children Charity. The spirit and generosity of all of our team members has again been outstanding in supporting those less fortunate than us this Xmas.”

Christmas Jumper Day:

Positive Early-Stage Clinical Data for Biogen Alzheimer’s Drug

Positive Early-Stage Clinical Data for Biogen Alzheimer's DrugBiogen Idec has announced plans to move their investigational Alzheimer’s drug into Phase III trials, after receiving promising early-stage clinical data.

Douglas Williams, Biogen Idec’s R&D chief, noted that in the interim analysis of their Phase Ib clinical trial, aducanumab (also known as BIIB037) showed a significant reduction in the beta-amyloid protein in early-stage patients.  After 54 weeks, results showed that patients exhibited statistically significant cognitive improvements.

Continue reading

Clinical Professionals Donate 59 Boxes to the Rotary Shoebox Scheme

Clinical Professionals Donate 59 Boxes to the Rotary Shoebox SchemeThe Clinical Professionals Group have donated 59 boxes to this year’s Rotary Christmas Shoebox Scheme.

Boxes were brought by Clinical Professionals, and then filled and decorated by employees, with some employees opting to fill multiple boxes.

The scheme started in 1994, and provides presents for children, teenagers, families and the elderly in Central and Eastern Europe.  Boxes are marked as either Toys, Teenagers or Household and shipped out to contacts in the relevant countries, where they are then distributed to recipients.

The Rotary Club is a UK based charity, founded in 1905, which brings together a global network of volunteer leaders who dedicate their time and talent to tackle the world’s most pressing humanitarian challenges.  The charity impacts lives at both the local and international levels, from helping communities to working to address global health problems.

Clinical Professionals CEO Yvette Cleland commented: “The Clinical Professionals Group has been involved in multiple charity events in 2014.  We wanted to ensure for Xmas that we contributed to individuals less fortunate and privileged than ourselves and the Rotary Club Gift Box Scheme seemed an outstanding way of offering gifts in a more personalised way. I feel proud to be part of such a generous and spirited team.”

Find out more about the Rotary Shoebox Scheme

UK Launches Innovative Medicines and MedTech Review

UK Launches Innovative Medicines and MedTech ReviewThe UK government has announced an innovative medicines review and increased funding for the life sciences sector.

The Innovative Medicines and MedTech Review has been created to see how new approaches to the development of drugs, diagnostics and devices, “based on precision medicine and emerging technologies, could speed up access to innovative products for NHS patients.”

Continue reading

Bayer Starts Phase II Clinical Trial of Riociguat

Bayer Starts Phase II Clinical Trial of RiociguatBayer HealthCare has confirmed that they have begun a Phase II clinical trial of riociguat for the treatment of diffuse cutaneous systemic sclerosis (dcSSc).

Systemic sclerosis is a rare multisystem, autoimmune disease that results in the overproduction and abnormal growth of collagen, which causes fibrosis of the skin and internal organs.  dcSSc is one of the two main forms of SSc and the most fatal rheumatic disease, which mainly affects people in their 40s and 50s.

The randomized, double-blind, placebo-controlled RISE-SSc clinical trial aims to assess the efficacy and safety of riociguat compared to placebo.

Continue reading

European Commission Partners with Pharma for €280m Ebola Initiative

European Commission Partners with Pharma for €280m Ebola InitiativeThe European Commission yesterday announced a new initiative with the European pharmaceutical industry for proposals under the Innovative Medicines Initiative to boost European research into Ebola.

The Innovative Medicines Initiative aims to improve healthcare by quickening the development of, and patient access to, innovative medicines, principally in areas where there is an unmet need for treatment.

The initiative is being funded equally by Horizon 2020 and pharmaceutical companies that are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA), with a combined total of 280 million Euros.

Continue reading

Novo Nordisk Announce 750 Million Kroner Investment in R&D Lab

Novo Nordisk Announce 750 Million Kroner Investment in R&D LabNovo Nordisk has confirmed that they are investing around 750 million kroner (roughly equivalent to $130 million) on new diabetes laboratories at the R&D campus in Måløv, Denmark.

Construction of the new laboratories has already started and the new facility, to be named the Diabetes Research House, will open in early 2016.

The Diabetes Research House will house 350 employees, proving employees with “an environment for cutting-edge diabetes research within biotechnology and protein chemistry,” according to Novo Nordisk’s chief science officer, Mads Krogsgaard.

Continue reading

Roche to Invest 3 Billion Swiss Francs on Basel Site

Roche to Invest 3 Billion Swiss Francs on Basel SiteRoche has today announced new plans to spend 3 billion Swiss francs on upgrading and constructing new labs in Basel, Switzerland.

Roche have put the plans forward to invest in creating modern, sustainable workplaces for their employees based in their site in Basel, Switzerland, creating new state-of-the-art offices.

The plans include the construction of a new research centre for roughly 1,900 employees, designed with the R&D part of the organisation “to ensure that scientists’ needs are fully met.”  The project is expected to be completed between 2021 and 2022, and the new building will contain 950 offices and 950 laboratory workplaces “that meet state-of-the-art requirements.”

Continue reading

Clinical Professionals Group to Attend the 2014 Partnerships in Clinical Trials

Clinical Professionals Group to Attend the 2014 Partnerships in Clinical Trials

Clinical Professionals will be exhibiting at this year’s Partnerships in Clinical Trials (PCT) conference in Barcelona, Spain.

Visit us at stand 715 or arrange a meeting with our team in advance.

After years of increasing staff turnover in essential roles such as CTA’s and CRA’s and no volume graduate programs in place Clinical Professionals now identifies, fully funds and trains the most talented Life Sciences University Graduates and deploys them into “first to industry” roles (CTA/CRA), ensuring our industry goes from strength to strength with new talent.  If you would like to understand more, or be part of this program, please join us on stand 715.

As Europe’s leading independent pharmaceutical staffing company, Clinical Professionals, provide clients with exceptional service and expertise of recruiting within life sciences across Europe, with nine out of 10 customers rating the Clinical Professionals Group as their most trusted partner*.

The Clinical Professionals Academy addresses both the issue of new entry level training investment, and creates an opportunity for the UK’s talented Life Science graduates to address the current skilled candidate shortfall in the Life Sciences sector.

The 2014 PCT conference will be taking place from the 5th – 6th November at the Centre de Convencions Internacional de Barcelona (CCIB) in Barcelona, Spain.  The conference will be the 13th annual Partnerships in Clinical Trials conference.  This year’s conference will focus on: embracing new technology; the effect of clinical trial transparency; and compliance requirements.

To find out more about being involved with Clinical Professionals Graduate Academy, or to arrange a meeting with our team, please contact us at:

Find out more about PCT 2014:

Find out more about Clinical Professionals Graduate Academy:

*Independent research conducted in 2013.